Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kidney Failure, Chronic | 64 | 2021 | 3222 | 7.85 | Why? |
| Renal Dialysis | 55 | 2021 | 4358 | 5.89 | Why? |
| Renal Insufficiency, Chronic | 28 | 2021 | 2654 | 2.57 | Why? |
| Kidney Diseases | 10 | 2021 | 1434 | 2.51 | Why? |
| Diabetic Nephropathies | 6 | 2018 | 315 | 2.32 | Why? |
| Kidney | 18 | 2021 | 3648 | 2.03 | Why? |
| Acidosis, Lactic | 3 | 2017 | 83 | 1.86 | Why? |
| Glomerular Filtration Rate | 19 | 2018 | 1262 | 1.72 | Why? |
| Dietary Proteins | 6 | 2018 | 112 | 1.64 | Why? |
| Protein-Energy Malnutrition | 5 | 2018 | 37 | 1.46 | Why? |
| Hemodialysis, Home | 3 | 2018 | 178 | 1.37 | Why? |
| Urea | 6 | 2018 | 228 | 1.25 | Why? |
| Hyperkalemia | 2 | 2018 | 140 | 1.24 | Why? |
| Precision Medicine | 5 | 2018 | 1477 | 1.23 | Why? |
| Metformin | 3 | 2017 | 640 | 1.13 | Why? |
| Alkaline Phosphatase | 4 | 2018 | 257 | 1.13 | Why? |
| Potassium | 4 | 2018 | 325 | 0.93 | Why? |
| Peritoneal Dialysis | 5 | 2018 | 498 | 0.92 | Why? |
| Hyperphosphatemia | 2 | 2018 | 20 | 0.91 | Why? |
| Potassium, Dietary | 2 | 2018 | 10 | 0.89 | Why? |
| Ultrafiltration | 2 | 2018 | 42 | 0.88 | Why? |
| Phosphorus | 5 | 2018 | 80 | 0.87 | Why? |
| Diet, Protein-Restricted | 2 | 2018 | 80 | 0.85 | Why? |
| Hemodialysis Solutions | 1 | 2018 | 18 | 0.77 | Why? |
| Inappropriate ADH Syndrome | 1 | 2020 | 72 | 0.77 | Why? |
| Ferritins | 3 | 2017 | 2055 | 0.75 | Why? |
| Iron | 3 | 2017 | 619 | 0.74 | Why? |
| Nephritis, Hereditary | 1 | 2017 | 6 | 0.74 | Why? |
| Sucrose | 1 | 2018 | 22 | 0.73 | Why? |
| Parathyroidectomy | 1 | 2018 | 32 | 0.72 | Why? |
| Hyperparathyroidism, Secondary | 1 | 2018 | 47 | 0.72 | Why? |
| Hypothyroidism | 2 | 2018 | 239 | 0.71 | Why? |
| Diet, Sodium-Restricted | 1 | 2017 | 23 | 0.71 | Why? |
| Proportional Hazards Models | 19 | 2018 | 6543 | 0.70 | Why? |
| Diet | 7 | 2020 | 2052 | 0.70 | Why? |
| Canagliflozin | 1 | 2017 | 56 | 0.68 | Why? |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2017 | 27 | 0.67 | Why? |
| Hypotension | 2 | 2018 | 392 | 0.67 | Why? |
| Hematinics | 1 | 2017 | 48 | 0.67 | Why? |
| Cachexia | 3 | 2020 | 75 | 0.66 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.65 | Why? |
| Quinazolinones | 1 | 2018 | 135 | 0.65 | Why? |
| Hyponatremia | 1 | 2020 | 371 | 0.61 | Why? |
| Eating | 2 | 2018 | 395 | 0.60 | Why? |
| Malnutrition | 3 | 2017 | 932 | 0.60 | Why? |
| Nephrology | 4 | 2018 | 546 | 0.59 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.59 | Why? |
| Kidney Transplantation | 7 | 2021 | 5397 | 0.58 | Why? |
| Gastroenteritis | 1 | 2020 | 489 | 0.57 | Why? |
| Serum Albumin, Human | 1 | 2017 | 265 | 0.57 | Why? |
| Renal Replacement Therapy | 3 | 2018 | 1530 | 0.56 | Why? |
| Conservative Treatment | 2 | 2017 | 349 | 0.55 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.55 | Why? |
| Societies, Scientific | 1 | 2018 | 414 | 0.54 | Why? |
| Cholesterol, HDL | 2 | 2018 | 439 | 0.54 | Why? |
| Atherosclerosis | 2 | 2013 | 768 | 0.54 | Why? |
| Biomarkers | 11 | 2018 | 23361 | 0.53 | Why? |
| Biosimilar Pharmaceuticals | 1 | 2017 | 205 | 0.52 | Why? |
| Hypoglycemia | 1 | 2018 | 406 | 0.51 | Why? |
| Death, Sudden, Cardiac | 1 | 2018 | 522 | 0.51 | Why? |
| Veterans | 12 | 2018 | 1131 | 0.50 | Why? |
| Cause of Death | 7 | 2018 | 4823 | 0.48 | Why? |
| Obesity | 6 | 2020 | 7388 | 0.48 | Why? |
| Thrombocytosis | 1 | 2011 | 21 | 0.46 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.45 | Why? |
| Acute Kidney Injury | 5 | 2021 | 5762 | 0.45 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.44 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.43 | Why? |
| Hypoglycemic Agents | 3 | 2018 | 2165 | 0.42 | Why? |
| Survival Rate | 11 | 2018 | 9206 | 0.41 | Why? |
| Cardiovascular Diseases | 9 | 2018 | 11497 | 0.41 | Why? |
| Lactic Acid | 1 | 2013 | 393 | 0.41 | Why? |
| Altitude | 1 | 2014 | 311 | 0.40 | Why? |
| Platelet Count | 2 | 2017 | 1381 | 0.40 | Why? |
| Patient-Centered Care | 1 | 2018 | 860 | 0.40 | Why? |
| Calcium | 4 | 2018 | 708 | 0.39 | Why? |
| Humans | 117 | 2021 | 930598 | 0.39 | Why? |
| Hemoglobins | 4 | 2017 | 958 | 0.39 | Why? |
| Erythropoietin | 3 | 2017 | 167 | 0.39 | Why? |
| Kidney Function Tests | 4 | 2018 | 520 | 0.37 | Why? |
| Inflammation | 6 | 2017 | 13255 | 0.37 | Why? |
| Albuminuria | 3 | 2018 | 164 | 0.37 | Why? |
| Acidosis | 3 | 2018 | 125 | 0.36 | Why? |
| Middle Aged | 60 | 2020 | 270681 | 0.36 | Why? |
| Quality of Life | 6 | 2018 | 9820 | 0.36 | Why? |
| Dialysis Solutions | 2 | 2018 | 76 | 0.35 | Why? |
| Risk Assessment | 9 | 2018 | 25439 | 0.34 | Why? |
| Clinical Decision-Making | 2 | 2019 | 3755 | 0.34 | Why? |
| Risk Factors | 32 | 2020 | 71621 | 0.33 | Why? |
| Renal Elimination | 2 | 2017 | 62 | 0.33 | Why? |
| United States | 29 | 2020 | 46150 | 0.33 | Why? |
| Aged | 51 | 2018 | 215776 | 0.33 | Why? |
| Arteriovenous Shunt, Surgical | 2 | 2018 | 93 | 0.33 | Why? |
| Constipation | 2 | 2018 | 99 | 0.32 | Why? |
| Blood Urea Nitrogen | 2 | 2017 | 206 | 0.31 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.31 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.31 | Why? |
| Transitional Care | 2 | 2018 | 135 | 0.31 | Why? |
| Time Factors | 15 | 2020 | 31397 | 0.31 | Why? |
| Male | 64 | 2020 | 367725 | 0.31 | Why? |
| Serum Amyloid P-Component | 1 | 2007 | 193 | 0.30 | Why? |
| Disease Progression | 10 | 2018 | 13580 | 0.30 | Why? |
| Female | 63 | 2020 | 380317 | 0.29 | Why? |
| Serum Albumin | 3 | 2017 | 571 | 0.28 | Why? |
| Follow-Up Studies | 9 | 2018 | 17020 | 0.28 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.28 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2018 | 6166 | 0.27 | Why? |
| Blood Pressure | 5 | 2018 | 2198 | 0.27 | Why? |
| Cohort Studies | 20 | 2019 | 36005 | 0.27 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.25 | Why? |
| Mortality | 2 | 2017 | 7132 | 0.25 | Why? |
| Hemodiafiltration | 2 | 2021 | 65 | 0.25 | Why? |
| Administration, Intravenous | 2 | 2017 | 1115 | 0.25 | Why? |
| Treatment Outcome | 14 | 2021 | 51732 | 0.24 | Why? |
| Bicarbonates | 2 | 2018 | 33 | 0.24 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.23 | Why? |
| Hospitalization | 6 | 2018 | 54280 | 0.23 | Why? |
| Creatinine | 4 | 2017 | 1443 | 0.23 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.21 | Why? |
| Neurosecretory Systems | 1 | 2020 | 48 | 0.21 | Why? |
| Catheters, Indwelling | 2 | 2018 | 84 | 0.21 | Why? |
| Patient Transfer | 2 | 2018 | 898 | 0.21 | Why? |
| Nephritis, Interstitial | 1 | 2021 | 83 | 0.20 | Why? |
| Retrospective Studies | 21 | 2018 | 105322 | 0.20 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.19 | Why? |
| Calcimimetic Agents | 1 | 2018 | 3 | 0.19 | Why? |
| Vascular Access Devices | 2 | 2017 | 122 | 0.19 | Why? |
| Annual Reports as Topic | 1 | 2018 | 13 | 0.19 | Why? |
| Neuroimmunomodulation | 1 | 2020 | 154 | 0.19 | Why? |
| Urine Specimen Collection | 1 | 2018 | 13 | 0.19 | Why? |
| North Carolina | 1 | 2021 | 571 | 0.19 | Why? |
| Anemia | 2 | 2017 | 789 | 0.19 | Why? |
| Acid-Base Imbalance | 1 | 2018 | 46 | 0.18 | Why? |
| Thyrotropin | 2 | 2017 | 262 | 0.18 | Why? |
| Recommended Dietary Allowances | 1 | 2018 | 43 | 0.18 | Why? |
| Longitudinal Studies | 4 | 2017 | 9893 | 0.18 | Why? |
| Nutritional Status | 3 | 2018 | 1403 | 0.18 | Why? |
| Water-Electrolyte Balance | 1 | 2018 | 136 | 0.18 | Why? |
| Biological Variation, Individual | 1 | 2017 | 66 | 0.18 | Why? |
| Body Mass Index | 4 | 2018 | 4306 | 0.18 | Why? |
| Sodium, Dietary | 1 | 2018 | 45 | 0.18 | Why? |
| California | 4 | 2017 | 2047 | 0.18 | Why? |
| Dietary Fiber | 1 | 2018 | 73 | 0.18 | Why? |
| Oleanolic Acid | 1 | 2018 | 82 | 0.18 | Why? |
| Hyperthyroidism | 1 | 2018 | 63 | 0.17 | Why? |
| Waist Circumference | 1 | 2018 | 199 | 0.17 | Why? |
| Epoetin Alfa | 1 | 2017 | 13 | 0.17 | Why? |
| Phosphorus, Dietary | 1 | 2016 | 4 | 0.17 | Why? |
| United States Department of Veterans Affairs | 2 | 2018 | 553 | 0.17 | Why? |
| Cheese | 1 | 2016 | 8 | 0.17 | Why? |
| Prognosis | 7 | 2018 | 32490 | 0.17 | Why? |
| Parathyroid Hormone | 1 | 2017 | 98 | 0.17 | Why? |
| African Americans | 4 | 2017 | 3363 | 0.16 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.16 | Why? |
| Chelating Agents | 1 | 2017 | 61 | 0.16 | Why? |
| Restless Legs Syndrome | 1 | 2017 | 53 | 0.16 | Why? |
| Thoracic Vertebrae | 1 | 2017 | 97 | 0.16 | Why? |
| Phosphates | 1 | 2017 | 135 | 0.16 | Why? |
| Water-Electrolyte Imbalance | 1 | 2017 | 119 | 0.16 | Why? |
| Plants, Edible | 1 | 2016 | 112 | 0.16 | Why? |
| Nutritional Requirements | 1 | 2017 | 115 | 0.16 | Why? |
| Meals | 1 | 2018 | 205 | 0.16 | Why? |
| Erythropoiesis | 1 | 2017 | 71 | 0.16 | Why? |
| Magnesium | 1 | 2018 | 290 | 0.15 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.15 | Why? |
| Fruit | 1 | 2018 | 313 | 0.15 | Why? |
| Observational Studies as Topic | 3 | 2018 | 1887 | 0.15 | Why? |
| Lumbar Vertebrae | 1 | 2017 | 196 | 0.15 | Why? |
| Antioxidants | 2 | 2018 | 1593 | 0.15 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.15 | Why? |
| Vegetables | 1 | 2018 | 340 | 0.15 | Why? |
| Adult | 21 | 2020 | 244371 | 0.14 | Why? |
| Incidence | 10 | 2018 | 25622 | 0.14 | Why? |
| Nephrotic Syndrome | 1 | 2017 | 146 | 0.14 | Why? |
| Immunomodulation | 2 | 2020 | 1472 | 0.14 | Why? |
| Databases, Factual | 3 | 2018 | 6248 | 0.14 | Why? |
| Nutrition Therapy | 1 | 2018 | 285 | 0.13 | Why? |
| Micronutrients | 1 | 2018 | 310 | 0.13 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.13 | Why? |
| Asian Americans | 1 | 2017 | 387 | 0.13 | Why? |
| Meat | 1 | 2016 | 380 | 0.13 | Why? |
| Albumins | 2 | 2017 | 324 | 0.13 | Why? |
| Nanotechnology | 1 | 2020 | 821 | 0.13 | Why? |
| Cell Hypoxia | 1 | 2014 | 141 | 0.13 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.13 | Why? |
| Wasting Syndrome | 1 | 2013 | 42 | 0.13 | Why? |
| Thyroid Diseases | 1 | 2017 | 285 | 0.13 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.12 | Why? |
| Chronic Disease | 3 | 2018 | 5139 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Withholding Treatment | 1 | 2019 | 798 | 0.12 | Why? |
| Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.12 | Why? |
| Graft Rejection | 2 | 2020 | 1766 | 0.12 | Why? |
| Thyroid Gland | 1 | 2017 | 516 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Apolipoprotein A-I | 1 | 2013 | 148 | 0.12 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.12 | Why? |
| Disasters | 1 | 2021 | 760 | 0.11 | Why? |
| Confusion | 1 | 2013 | 256 | 0.11 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.11 | Why? |
| Dialysis | 1 | 2011 | 45 | 0.11 | Why? |
| Testosterone | 1 | 2017 | 596 | 0.11 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.11 | Why? |
| Aged, 80 and over | 12 | 2020 | 88759 | 0.11 | Why? |
| Drug Approval | 2 | 2020 | 1325 | 0.11 | Why? |
| Sarcopenia | 2 | 2020 | 422 | 0.11 | Why? |
| Pancreas Transplantation | 1 | 2013 | 163 | 0.11 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.11 | Why? |
| Odds Ratio | 3 | 2018 | 5861 | 0.11 | Why? |
| C-Reactive Protein | 1 | 2007 | 7972 | 0.11 | Why? |
| Mobility Limitation | 1 | 2011 | 153 | 0.10 | Why? |
| Prevalence | 7 | 2018 | 25773 | 0.10 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.10 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| Smoking Cessation | 1 | 2018 | 826 | 0.10 | Why? |
| Proteins | 1 | 2018 | 921 | 0.10 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.10 | Why? |
| Pancreas | 1 | 2013 | 398 | 0.10 | Why? |
| Gastrointestinal Microbiome | 2 | 2020 | 1961 | 0.10 | Why? |
| Hydrogen-Ion Concentration | 1 | 2013 | 993 | 0.10 | Why? |
| Health Status | 3 | 2018 | 3259 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Bipolar Disorder | 1 | 2018 | 744 | 0.10 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.10 | Why? |
| Cholesterol, LDL | 1 | 2013 | 499 | 0.09 | Why? |
| Coronary Disease | 1 | 2015 | 645 | 0.09 | Why? |
| Drug Industry | 1 | 2017 | 689 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Vomiting | 1 | 2013 | 722 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Psychotic Disorders | 1 | 2018 | 924 | 0.09 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.09 | Why? |
| Abdominal Pain | 1 | 2013 | 858 | 0.08 | Why? |
| Consensus | 2 | 2013 | 6345 | 0.08 | Why? |
| Commerce | 1 | 2017 | 1109 | 0.08 | Why? |
| Sleep Apnea, Obstructive | 1 | 2015 | 668 | 0.08 | Why? |
| Morbidity | 3 | 2017 | 1426 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Dyslipidemias | 1 | 2013 | 791 | 0.08 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1692 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.08 | Why? |
| Ambulatory Care Facilities | 1 | 2018 | 2063 | 0.08 | Why? |
| Veterans Health | 2 | 2017 | 169 | 0.08 | Why? |
| Animals | 5 | 2020 | 78931 | 0.08 | Why? |
| Biosensing Techniques | 1 | 2020 | 2116 | 0.08 | Why? |
| Laparoscopy | 1 | 2017 | 1532 | 0.07 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.07 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Pancreatitis | 1 | 2013 | 688 | 0.07 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.07 | Why? |
| Comorbidity | 6 | 2018 | 34796 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.07 | Why? |
| Age Factors | 4 | 2018 | 21039 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.06 | Why? |
| Sex Factors | 2 | 2017 | 11014 | 0.06 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2018 | 3419 | 0.06 | Why? |
| Internationality | 2 | 2018 | 3297 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Antirheumatic Agents | 1 | 2018 | 3023 | 0.06 | Why? |
| Depression | 2 | 2017 | 14116 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.06 | Why? |
| Oxidative Stress | 1 | 2013 | 2050 | 0.06 | Why? |
| Protective Factors | 2 | 2018 | 1720 | 0.06 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.06 | Why? |
| Energy Metabolism | 2 | 2018 | 451 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.06 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.05 | Why? |
| Registries | 2 | 2017 | 12327 | 0.05 | Why? |
| Anticoagulants | 2 | 2017 | 9563 | 0.05 | Why? |
| Sleep Aids, Pharmaceutical | 1 | 2018 | 52 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Diagnosis, Differential | 1 | 2013 | 7220 | 0.05 | Why? |
| Appetite | 1 | 2018 | 74 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.04 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2013 | 1969 | 0.04 | Why? |
| Urodynamics | 1 | 2018 | 51 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Diabetic Neuropathies | 1 | 2018 | 64 | 0.04 | Why? |
| Food Additives | 1 | 2016 | 27 | 0.04 | Why? |
| Thyroid Function Tests | 1 | 2017 | 200 | 0.04 | Why? |
| Ultrasonography | 1 | 2013 | 4409 | 0.04 | Why? |
| Whole Body Imaging | 1 | 2017 | 116 | 0.04 | Why? |
| Nutrition Policy | 1 | 2018 | 132 | 0.04 | Why? |
| Hawaii | 1 | 2017 | 163 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Stroke | 2 | 2017 | 8839 | 0.04 | Why? |
| Adiposity | 1 | 2018 | 329 | 0.04 | Why? |
| Central Venous Catheters | 1 | 2017 | 188 | 0.04 | Why? |
| Energy Intake | 1 | 2017 | 323 | 0.04 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.04 | Why? |
| Outpatients | 2 | 2018 | 3417 | 0.03 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2018 | 527 | 0.03 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.03 | Why? |
| Anti-Inflammatory Agents | 1 | 2013 | 6153 | 0.03 | Why? |
| Research Report | 1 | 2018 | 376 | 0.03 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.03 | Why? |
| Adipokines | 1 | 2013 | 87 | 0.03 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.03 | Why? |
| Obesity, Abdominal | 1 | 2013 | 167 | 0.03 | Why? |
| Societies, Medical | 2 | 2018 | 6907 | 0.03 | Why? |
| Motor Activity | 1 | 2013 | 217 | 0.03 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Diabetes Mellitus | 1 | 2011 | 8207 | 0.02 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.02 | Why? |
| Iran | 1 | 2017 | 5467 | 0.02 | Why? |
| Muscle, Skeletal | 1 | 2011 | 915 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.02 | Why? |
| Young Adult | 3 | 2017 | 93724 | 0.01 | Why? |
| Aging | 1 | 2017 | 3581 | 0.01 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Life Style | 1 | 2013 | 2708 | 0.01 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2017 | 53120 | 0.01 | Why? |
| Pulmonary Embolism | 1 | 2017 | 4775 | 0.01 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2016 | 48226 | 0.01 | Why? |
Kalantar-Zadeh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(348)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_